Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Brain Sciences|December 23, 2022
Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in MiceKelly F Paton, Sheein Hong, Andrew Biggerstaff, et al.Scientific Reports|June 5, 2017
Metabolic responses of a phototrophic sponge to sedimentation supports transitions to sponge-dominated reefsAndrew Biggerstaff, David J Smith, Jamaluddin Jompa, et al.Conservation Biology : the Journal of the Society for Conservation Biology|January 21, 2015
Global conservation status of spongesJames J Bell, Emily McGrath, Andrew Biggerstaff, et al.Marine Pollution Bulletin|April 6, 2015
Sediment impacts on marine spongesJames J Bell, Emily McGrath, Andrew Biggerstaff, et al.Frontiers in Neuroscience|August 15, 2020
Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of PainKelly F Paton, Andrew Biggerstaff, Sophia Kaska, et al.Journal of Medicinal Chemistry|April 5, 2017
Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic StabilityAlexander M Sherwood, Rachel Saylor Crowley, Kelly F Paton, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2025
Role of β-Arrestin 2 in the antinociceptive and side effect profile of morphine and the novel mu opioid receptor agonists, kurkinorin and kurkinolRoss van de Wetering, Amy F Alder, Andrew Biggerstaff, et al.Molecules (Basel, Switzerland)|October 14, 2018
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in RodentsBronwyn M Kivell, Kelly F Paton, Nitin Kumar, et al.Pharmacology, Biochemistry, and Behavior|January 18, 2022
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disordersJeffrey M Witkin, Arnold Lippa, Jodi L Smith, et al.Pageof 1